Single hormone or synthetic agonist induces Gs/Gicoupling selectivity of EP receptors via distinct binding modes and propagating paths
Open Access
- 21 July 2023
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 120 (30)
Abstract
To accomplish concerted physiological reactions, nature has diversified functions of a single hormone at at least two primary levels: 1) Different receptors recognize the same hormone, and 2) different cellular effectors couple to the same hormone–receptor pair [R.P. Xiao,Sci STKE2001, re15 (2001); L. Hein, J. D. Altman, B.K. Kobilka,Nature402, 181–184 (1999); Y. Daaka, L. M. Luttrell, R. J. Lefkowitz,Nature390, 88–91 (1997)]. Not only these questions lie in the heart of hormone actions and receptor signaling but also dissecting mechanisms underlying these questions could offer therapeutic routes for refractory diseases, such as kidney injury (KI) or X-linked nephrogenic diabetes insipidus (NDI). Here, we identified that Gs-biased signaling, but not Giactivation downstream of EP4, showed beneficial effects for both KI and NDI treatments. Notably, by solving Cryo-electron microscope (cryo-EM) structures of EP3-Gi, EP4-Gs, and EP4-Giin complex with endogenous prostaglandin E2(PGE2)or two synthetic agonists and comparing with PGE2-EP2-Gsstructures, we found that unique primary sequences of prostaglandin E2 receptor (EP) receptors and distinct conformational states of the EP4 ligand pocket govern the Gs/Gitransducer coupling selectivity through different structural propagation paths, especially via TM6 and TM7, to generate selective cytoplasmic structural features. In particular, the orientation of the PGE2ω-chain and two distinct pockets encompassing agonist L902688 of EP4 were differentiated by their Gs/Gicoupling ability. Further, we identified common and distinct features of cytoplasmic side of EP receptors for Gs/Gicoupling and provide a structural basis for selective and biased agonist design of EP4 with therapeutic potential.Keywords
Funding Information
- MOST | National Key Research and Development Program of China (2019YFA0904200)
- MOST | NSFC | National Science Fund for Distinguished Young Scholars (81825022)
- National Science Fund for Excellent Young Scholars Grant (81822008)
- National Science Fund for Excellent Young Scholars Grant (82122070)
- State Key Program of National Natural Science Foundation of China (32130055)
- Beijing Natural Science Foundation (Z200019)
- MOST | National Natural Science Foundation of China ((91939301)
- MOST | National Natural Science Foundation of China (92057121)
- MOST | National Natural Science Foundation of China (31900936)
- MOST | National Natural Science Foundation of China (31971195)
- MOST | National Natural Science Foundation of China (82104272)
This publication has 78 references indexed in Scilit:
- Acute kidney injuryThe Lancet, 2012
- Quantifying Ligand Bias at Seven-Transmembrane ReceptorsMolecular Pharmacology, 2011
- Crystal structure of the β2 adrenergic receptor–Gs protein complexNature, 2011
- EP4 receptor stimulation down-regulates human eosinophil functionCellular and Molecular Life Sciences, 2011
- A selective EP4 PGE2 receptor agonist alleviates disease in a new mouse model of X-linked nephrogenic diabetes insipidusJournal of Clinical Investigation, 2009
- Macrophage EP4 Deficiency Increases Apoptosis and Suppresses Early AtherosclerosisCell Metabolism, 2008
- Cyclooxygenase-2 Up-regulates CCR7 via EP2/EP4 Receptor Signaling Pathways to Enhance Lymphatic Invasion of Breast Cancer Cells*Journal of Biological Chemistry, 2008
- EP4 Prostanoid Receptor Coupling to a Pertussis Toxin-Sensitive Inhibitory G ProteinMolecular Pharmacology, 2006
- An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and BehaviorCell, 2005
- Protein Kinase A-mediated Phosphorylation of the β2-Adrenergic Receptor Regulates Its Coupling to Gs and GiJournal of Biological Chemistry, 2002